Catalyst Pharmaceuticals Inc (CPRX)
5.81
+0.08 +1.40%
NASDAQ
Jun 21, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 120.14M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.68 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 72.22M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 84.50% |
| Profit Margin (Quarterly) | 25.37% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 600.55M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 5.145 |
| PE Ratio | 8.544 |
| Price to Book Value | 3.362 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | 2.903M |
| Return on Equity | Upgrade |
View All CPRX News
News
-
WireHeadlineTime (ET)
-
Yahoo06/16 02:38
-
Yahoo06/09 11:30
-
Yahoo06/08 15:16
-
PR Newswire06/03 15:09
-
Globe Newswire06/03 13:20
-
Yahoo06/01 16:39
-
Globe Newswire05/19 08:03
-
MT Newswires05/12 10:50
-
Yahoo05/11 06:30
-
Yahoo05/11 03:06
-
Yahoo05/10 19:05
-
MT Newswires05/10 17:31
-
Globe Newswire05/10 17:29
-
Yahoo05/08 06:12
-
Yahoo05/03 15:01
-
Globe Newswire05/03 08:05
-
Yahoo04/14 11:30
-
Yahoo04/05 01:03
-
MT Newswires03/22 10:03
-
PR Newswire03/22 09:31
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/11/2021 08:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 08/10/2021 | Earnings Results | Q2 2021 Earnings Results |
| 05/11/2021 08:30 EST | Earnings Calls | Q1 2021 Earnings Call |
| 05/10/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/16/2021 08:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 03/15/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/10/2020 08:30 EST | Earnings Calls | Q3 2020 Earnings Call |
| 11/09/2020 | Earnings Results | Q3 2020 Earnings Results |
| 08/20/2020 09:00 EST | AGM | 2019 Annual General Meeting |
| 08/11/2020 08:30 EST | Earnings Calls | Q2 2020 Earnings Call |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with the lambert-eaton myasthenic syndrome.
- URL: https://www.catalystpharma.com
- Investor Relations URL: https://ir.catalystpharma.com/
- HQ State/Province: Florida
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Aug. 10, 2021
- Last Earnings Release: May. 10, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 5.81 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| TGFRX | Tanaka Growth | 1.35% |
| ROSC | Hartford Multifactor Small Cap ETF | 0.80% |
| BFOR | Barron's 400 ETF | 0.34% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CPRX Tweets Stocktwits
Advertisement
